Stock NGVT INGEVITY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ingevity Corporation

Equities

NGVT

US45688C1071

Diversified Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
48.85 USD +1.75% Intraday chart for Ingevity Corporation +2.33% +3.45%
May. 07 Loop Capital Adjusts Price Target on Ingevity to $56 From $49, Maintains Hold Rating MT
May. 02 Transcript : Ingevity Corporation, Q1 2024 Earnings Call, May 02, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,655 3,126 2,817 2,632 1,711 1,775 - -
Enterprise Value (EV) 1 4,827 4,136 3,791 4,028 3,082 3,054 2,737 2,660
P/E ratio 20.1 x 16.9 x 24.3 x 12.8 x -315 x 29.3 x 10.2 x 8.34 x
Yield - - - - - - - -
Capitalization / Revenue 2.83 x 2.57 x 2.02 x 1.58 x 1.01 x 1.19 x 1.14 x 1.11 x
EV / Revenue 3.73 x 3.4 x 2.72 x 2.41 x 1.82 x 2.04 x 1.76 x 1.66 x
EV / EBITDA 12.2 x 10.4 x 8.98 x 8.9 x 7.77 x 8.01 x 6.16 x 5.7 x
EV / FCF 30 x 15.3 x 20 x 23.6 x 32.3 x 30.8 x 10.2 x 14.2 x
FCF Yield 3.33% 6.54% 4.99% 4.24% 3.09% 3.24% 9.79% 7.03%
Price to Book 6.89 x 4.9 x 4.18 x 3.76 x - - - -
Nbr of stocks (in thousands) 41,824 41,279 39,286 37,372 36,231 36,329 - -
Reference price 2 87.38 75.73 71.70 70.44 47.22 48.85 48.85 48.85
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,293 1,216 1,392 1,668 1,692 1,497 1,555 1,598
EBITDA 1 396.9 397.9 422.2 452.6 396.8 381.2 444 466.5
EBIT 1 311.9 297.7 312.3 343.8 76.9 260.4 327.7 346
Operating Margin 24.12% 24.48% 22.44% 20.61% 4.54% 17.4% 21.07% 21.65%
Earnings before Tax (EBT) 1 227.9 235.1 162.8 269.6 -10.1 75.03 230.2 282
Net income 1 183.7 186.2 118.1 211.6 -5.4 48.38 177.2 217
Net margin 14.21% 15.31% 8.49% 12.68% -0.32% 3.23% 11.4% 13.58%
EPS 2 4.350 4.480 2.950 5.500 -0.1500 1.670 4.778 5.860
Free Cash Flow 1 160.9 270.3 189.2 170.6 95.3 99 268 187
FCF margin 12.44% 22.23% 13.6% 10.23% 5.63% 6.61% 17.23% 11.7%
FCF Conversion (EBITDA) 40.54% 67.93% 44.81% 37.69% 24.02% 25.97% 60.36% 40.09%
FCF Conversion (Net income) 87.59% 145.17% 160.2% 80.62% - 204.65% 151.22% 86.18%
Dividend per Share - - - - - - - -
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 336 382.8 419.9 482 383.6 392.6 481.8 446 371.7 340.1 412.4 410.1 331 326 456.1
EBITDA 1 79.6 119 121.1 138.2 74.3 103.9 120.7 110.4 61.8 76.9 104 111.6 87.44 89.33 130.9
EBIT 1 51.4 88.3 91.6 107.3 44.1 72.8 69.3 55.2 -131.3 47.3 72.25 84.9 59.05 72.7 112.5
Operating Margin 15.3% 23.07% 21.81% 22.26% 11.5% 18.54% 14.38% 12.38% -35.32% 13.91% 17.52% 20.7% 17.84% 22.3% 24.67%
Earnings before Tax (EBT) 1 36.3 77.6 76.5 95.8 19.7 64.1 47.7 32.1 -154 -71.9 50.2 54.97 30.07 33.8 77.1
Net income 1 29.3 60.8 59.8 75.4 15.6 50.7 35.5 25.2 -116.8 -56 35.27 40.05 21.12 25.87 59.23
Net margin 8.72% 15.88% 14.24% 15.64% 4.07% 12.91% 7.37% 5.65% -31.42% -16.47% 8.55% 9.76% 6.38% 7.93% 12.99%
EPS 2 0.7400 1.550 1.540 1.980 0.4100 1.350 0.9700 0.6900 -3.230 -1.540 1.060 1.153 0.6433 0.7100 1.620
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/23/22 5/4/22 8/2/22 11/2/22 2/27/23 5/3/23 8/2/23 11/1/23 2/21/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,172 1,010 975 1,396 1,371 1,279 962 885
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.953 x 2.538 x 2.308 x 3.084 x 3.456 x 3.356 x 2.167 x 1.897 x
Free Cash Flow 1 161 270 189 171 95.3 99 268 187
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 12.70 15.50 17.20 18.70 - - - -
Cash Flow per Share 2 6.530 8.480 7.310 - - 1.160 3.850 -
Capex 1 115 82.1 104 143 110 101 121 117
Capex / Sales 8.88% 6.75% 7.46% 8.54% 6.49% 6.77% 7.75% 7.32%
Announcement Date 2/3/20 2/10/21 2/23/22 2/27/23 2/21/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Ingevity Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
48.85 USD
Average target price
63.17 USD
Spread / Average Target
+29.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

1st Jan change Capi.
INGEVITY CORPORATION Stock Ingevity Corporation
+3.45% 1.77B
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
-1.05% 74.34B
BASF SE Stock BASF SE
-0.76% 46.86B
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+6.80% 34.35B
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+9.37% 18.1B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+12.81% 11.92B
SYENSQO SA/NV Stock Syensqo SA/NV
-3.01% 10.43B
BRENNTAG SE Stock Brenntag SE
-20.72% 10.33B
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-1.35% 9.04B
SRF LIMITED Stock SRF Limited
-11.01% 7.84B
Diversified Chemicals
  1. Stock Market
  2. Equities
  3. NGVT Stock
  4. Financials Ingevity Corporation